Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Melanoma today does not require radical surgery.

N P Lang, J M Stair, R D Degges

    American Journal of Surgery
    |December 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The doctor in this new day.

    Journal of the Medical Association of Georgia·2010
    Same author

    A phase I study of lenalidomide in combination with fludarabine and rituximab in previously untreated CLL/SLL.

    Leukemia·2010
    Same author

    The novel protein BboRhop68 is expressed by intraerythrocytic stages of Babesia bovis.

    Parasitology international·2010
    Same author

    A systematic review on animal models of maternal high fat feeding and offspring glycaemic control.

    International journal of obesity (2005)·2010
    Same author

    Multisensory determinants of orientation perception: task-specific sex differences.

    The European journal of neuroscience·2010
    Same author

    Changing concepts of homosexuality in psychoanalysis.

    Psychiatry·2010
    Same journal

    Innovative management of Anterior Cutaneous Nerve Entrapment Syndrome (ACNES): A meta-analysis and introduction of a new robotic approach with patient-based algorithm.

    American journal of surgery·2026
    Same journal

    Does the risk outweigh the benefit? Clot progression, recanalization & complications of anticoagulation therapy in acute pancreatitis with concomitant splanchnic vein thrombosis.

    American journal of surgery·2026
    Same journal

    High and low body mass index and 90-day postoperative outcomes in patients with Crohn's disease undergoing abdominal surgery.

    American journal of surgery·2026
    Same journal

    Women with firearm injuries: A multicenter mixed-methods study.

    American journal of surgery·2026
    Same journal

    SBAS presidential address: A surgeon-scientist's journey from haptic science to digital performance metrics.

    American journal of surgery·2026
    Same journal

    Using Dr. Google and AI to stay informed.

    American journal of surgery·2026
    See all related articles

    Melanoma outcomes have improved, with 2 cm margins offering good survival rates. Primary closure is best, but elective lymph node dissection offers questionable benefit for melanoma treatment.

    Area of Science:

    • Oncology
    • Dermatology
    • Surgical Oncology

    Background:

    • Melanoma treatment has evolved over the past two decades.
    • Optimizing surgical margins and lymph node management remains critical for patient outcomes.

    Purpose of the Study:

    • To evaluate current outcomes for melanoma patients.
    • To assess the efficacy of different surgical approaches, including margin size and lymph node dissection.

    Main Methods:

    • Retrospective analysis of melanoma patient data.
    • Comparison of survival and recurrence rates based on treatment parameters.

    Main Results:

    • Melanoma patients today experience more favorable outcomes compared to 20 years ago.
    • Surgical margins of 2 cm are associated with acceptable survival and local recurrence rates.

    Related Experiment Videos

  • Primary tumor closure is the preferred method when feasible.

    • Conclusions:

    • Current melanoma treatment strategies have improved patient prognosis.
    • The value of elective regional node dissection in melanoma requires further investigation.
    • Additional research is needed to define optimal therapies for intermediate-thickness melanoma.